Patent ID: 7576117
Filing Date: 2009-08-18
Classification: A61K,A61P,C07D

Abstract:
1. A method for treatment of allergic conjunctivitis, eosinophilia, eosinophilic gastroentereitis, eosinophilic enteropathy, eosinophilic fasciitis, eosinophilic granuloma, eosinophilic pustular folliculitis, and eosinophilic leukemia, comprising administering to a subject an effective amount of a compound having CCR3 antagonistic activity, wherein said compound is represented by the following formula (I), a pharmaceutically acceptable acid addition salt thereof, or a pharmaceutically acceptable C 1 to C 6 alkyl addition salt thereof, wherein, R R j is 0; k represents 0 or 1; m represents an integer of 2 to 3; n represents 0; R R p represents 0 or 1; q represents 0 or 1; G represents a group represented by —NR R wherein m+k is 3.